专题：Breast Cancer Treatment Studies

This cluster of papers focuses on molecular research, treatment response, and prognostic markers in breast cancer. It covers topics such as gene expression patterns, molecular subtypes, neoadjuvant therapy, radiotherapy, and the impact of hormone receptors on survival. The papers also discuss the development of clinical practice guidelines for breast cancer management.
最新文献
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex

Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole

article Full Text OpenAlex

Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast

article Full Text OpenAlex

Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child

article Full Text OpenAlex

Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2− Breast Cancer

review Full Text OpenAlex

Abstract GS03-03: Ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) as adjuvant treatment in patients with HR+/HER2− early breast cancer: final invasive disease–free survival (iDFS) analysis from the NATALEE trial

article Full Text OpenAlex

Effectiveness of gonadotropin-releasing hormone agonists for ovarian function suppression in premenopausal patients with hormone receptor-positive breast cancer: a retrospective single-center real-world study

article Full Text OpenAlex

Minimizing normal tissue low dose bath for left breast Volumetric Modulated Arc Therapy (VMAT) using jaw offset

article Full Text OpenAlex

Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study

article Full Text OpenAlex

Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer

article Full Text OpenAlex

近5年高被引文献
Breast Cancer Statistics, 2022

article Full Text OpenAlex 2223 FWCI322.2106356

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer

article Full Text OpenAlex 1671 FWCI164.5288604

Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review

review Full Text OpenAlex 1551 FWCI110.1841557

Breast cancer

review Full Text OpenAlex 1432 FWCI207.1185657

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

article Full Text OpenAlex 1145 FWCI145.38980445

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

article Full Text OpenAlex 975 FWCI132.55760298

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 901 FWCI117.05856017

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

article Full Text OpenAlex 874 FWCI118.96195139

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline

article Full Text OpenAlex 849 FWCI67.15681583

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

article Full Text OpenAlex 722 FWCI58.29510563